Smith & Nephew (SNN) Net Cash Flow Growth (5y) (2014 - 2024)
Smith & Nephew (SNN) Net Cash Flow Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Steris | 21.44 Bn | 21.00 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15.01% |
| Dec 31, 2023 | -28.70% |
| Dec 31, 2022 | 0.10% |
| Dec 31, 2021 | 4.38% |
| Dec 31, 2020 | 74.82% |
| Dec 31, 2019 | -31.73% |
| Dec 31, 2017 | -61.47% |
| Dec 31, 2016 | -22.31% |
| Dec 31, 2015 | -53.99% |
| Dec 31, 2014 | -23.84% |
| Sep 30, 2014 | -112.76% |
| Mar 31, 2014 | -19.15% |